Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


CNS Doses First Group Of Patients With Berubicin In Potentially Pivotal Study For Treatment Of Glioblastoma Multiforme


RTTNews | Sep 30, 2021 08:08AM EDT

08:08 Thursday, September 30, 2021 (RTTNews) - CNS Doses First Group Of Patients With Berubicin In Potentially Pivotal Study For Treatment Of Glioblastoma Multiforme

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC